212 related articles for article (PubMed ID: 12578384)
1. Comprehensive model for allosteric regulation of mammalian ribonucleotide reductase: refinements and consequences.
Kashlan OB; Cooperman BS
Biochemistry; 2003 Feb; 42(6):1696-706. PubMed ID: 12578384
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit.
Kashlan OB; Scott CP; Lear JD; Cooperman BS
Biochemistry; 2002 Jan; 41(2):462-74. PubMed ID: 11781084
[TBL] [Abstract][Full Text] [Related]
3. A kinetic study on the influence of nucleoside triphosphate effectors on subunit interaction in mouse ribonucleotide reductase.
Ingemarson R; Thelander L
Biochemistry; 1996 Jul; 35(26):8603-9. PubMed ID: 8679622
[TBL] [Abstract][Full Text] [Related]
4. The enantioselectivities of the active and allosteric sites of mammalian ribonucleotide reductase.
He J; Roy B; Périgaud C; Kashlan OB; Cooperman BS
FEBS J; 2005 Mar; 272(5):1236-42. PubMed ID: 15720397
[TBL] [Abstract][Full Text] [Related]
5. A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase.
Scott CP; Kashlan OB; Lear JD; Cooperman BS
Biochemistry; 2001 Feb; 40(6):1651-61. PubMed ID: 11327824
[TBL] [Abstract][Full Text] [Related]
6. Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data.
Radivoyevitch T
Biol Direct; 2009 Dec; 4():50. PubMed ID: 20003203
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase.
Reichard P; Eliasson R; Ingemarson R; Thelander L
J Biol Chem; 2000 Oct; 275(42):33021-6. PubMed ID: 10884394
[TBL] [Abstract][Full Text] [Related]
8. Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding.
Eriksson M; Uhlin U; Ramaswamy S; Ekberg M; Regnström K; Sjöberg BM; Eklund H
Structure; 1997 Aug; 5(8):1077-92. PubMed ID: 9309223
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.
Fairman JW; Wijerathna SR; Ahmad MF; Xu H; Nakano R; Jha S; Prendergast J; Welin RM; Flodin S; Roos A; Nordlund P; Li Z; Walz T; Dealwis CG
Nat Struct Mol Biol; 2011 Mar; 18(3):316-22. PubMed ID: 21336276
[TBL] [Abstract][Full Text] [Related]
10. Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.
Uppsten M; Färnegårdh M; Jordan A; Eliasson R; Eklund H; Uhlin U
J Mol Biol; 2003 Jun; 330(1):87-97. PubMed ID: 12818204
[TBL] [Abstract][Full Text] [Related]
11. Mutant R1 proteins from Escherichia coli class Ia ribonucleotide reductase with altered responses to dATP inhibition.
Birgander PL; Kasrayan A; Sjöberg BM
J Biol Chem; 2004 Apr; 279(15):14496-501. PubMed ID: 14752109
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by effectors and substrate nucleotides of R1-R2 interactions in Escherichia coli class Ia ribonucleotide reductase.
Kasrayan A; Birgander PL; Pappalardo L; Regnström K; Westman M; Slaby A; Gordon E; Sjöberg BM
J Biol Chem; 2004 Jul; 279(30):31050-7. PubMed ID: 15145955
[TBL] [Abstract][Full Text] [Related]
13. Diversity in Overall Activity Regulation of Ribonucleotide Reductase.
Jonna VR; Crona M; Rofougaran R; Lundin D; Johansson S; Brännström K; Sjöberg BM; Hofer A
J Biol Chem; 2015 Jul; 290(28):17339-48. PubMed ID: 25971975
[TBL] [Abstract][Full Text] [Related]
14. Chimeric small subunit inhibitors of mammalian ribonucleotide reductase: a dual function for the R2 C-terminus?
Hamann CS; Lentainge S; Li LS; Salem JS; Yang FD; Cooperman BS
Protein Eng; 1998 Mar; 11(3):219-24. PubMed ID: 9613846
[TBL] [Abstract][Full Text] [Related]
15. Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit.
Aye Y; Stubbe J
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9815-20. PubMed ID: 21628579
[TBL] [Abstract][Full Text] [Related]
16. Peptide inhibitors of mammalian ribonucleotide reductase.
Cooperman BS; Gao Y; Tan C; Kashlan OB; Kaur J
Adv Enzyme Regul; 2005; 45():112-25. PubMed ID: 16054677
[TBL] [Abstract][Full Text] [Related]
17. Formation of a free radical of the sulfenylimine type in the mouse ribonucleotide reductase reaction with 2'-azido-2'-deoxycytidine 5'-diphosphate.
Behravan G; Sen S; Rova U; Thelander L; Eckstein F; Gräslund A
Biochim Biophys Acta; 1995 Dec; 1264(3):323-9. PubMed ID: 8547320
[TBL] [Abstract][Full Text] [Related]
18. Allosteric Inhibition of Human Ribonucleotide Reductase by dATP Entails the Stabilization of a Hexamer.
Ando N; Li H; Brignole EJ; Thompson S; McLaughlin MI; Page JE; Asturias FJ; Stubbe J; Drennan CL
Biochemistry; 2016 Jan; 55(2):373-81. PubMed ID: 26727048
[TBL] [Abstract][Full Text] [Related]
19. An active ribonucleotide reductase from Arabidopsis thaliana cloning, expression and characterization of the large subunit.
Sauge-Merle S; Falconet D; Fontecave M
Eur J Biochem; 1999 Nov; 266(1):62-9. PubMed ID: 10542051
[TBL] [Abstract][Full Text] [Related]
20. 3.3-Å resolution cryo-EM structure of human ribonucleotide reductase with substrate and allosteric regulators bound.
Brignole EJ; Tsai KL; Chittuluru J; Li H; Aye Y; Penczek PA; Stubbe J; Drennan CL; Asturias F
Elife; 2018 Feb; 7():. PubMed ID: 29460780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
